Maximum doses of proton pump inhibitors in hepatic impairment

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-CPS-113
• By: MORGADO, Manuel (University of Beira Interior, Health Science Faculty)
• Co-author(s): Andreia Primo: Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal
  Inês Martins: Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal
  Luís Caetano: Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal
  Nuno Pereira: Higher School of Health, Polytechnic Institute of Guarda, Guarda, Portugal
  Ema Paulino: Portuguese Pharmaceutical Society, Lisbon, Portugal
  Manuel Morgado: Higher School of Health, Portuguese Pharmaceutical Society, Guarda, Portugal;Health Science Faculty, University of Beira Interior, Covilhã, Portugal;Pharmaceutical Services, Hospital Centre of Cova da Beira, Covilhã, Portugal
  
• Abstract:

  Background

  Some of the most commonly used drugs, including most proton pump inhibitors (PPIs) are eliminated by the hepatic route. If liver function is impaired, it can be anticipated that hepatic clearance will be delayed, which can lead to more pronounced drug accumulation.

  Methods

  The databases of the Nacional Authority of Medicines and Health
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login